Nitrogen-containing heterocyclic compound or salt thereof
US-2015322063-A1 · Nov 12, 2015 · US
Heteroaryls and uses thereof
US9751854B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9751854-B2 |
| Application number | US-201615347334-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 9, 2016 |
| Priority date | Jan 14, 2014 |
| Publication date | Sep 5, 2017 |
| Grant date | Sep 5, 2017 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention provides a compound of formula I: and pharmaceutically acceptable salts thereof, wherein X, R 1 , R 2 , R 3 , R 4 , R 5 , L 1 , L 2 , m, and n, are as described in the specification. Such compounds are inhibitors of VPS34 and thus useful for treating proliferative, inflammatory, or cardiovascular disorders.
First claim
Opening claim text (preview).
We claim: 1. A compound selected from the group consisting of: or a pharmaceutically acceptable salt thereof. 2. The compound of claim 1 , which is or a pharmaceutically acceptable salt thereof. 3. The compound of claim 1 , which is or a pharmaceutically acceptable salt thereof. 4. The compound of claim 1 , which is or a pharmaceutically acceptable salt thereof. 5. A pharmaceutical composition comprising the compound of claim 1 or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier. 6. The pharmaceutical composition of claim 5 , wherein the compound is or a pharmaceutically acceptable salt thereof. 7. The pharmaceutical composition of claim 5 , wherein the compound is or a pharmaceutically acceptable salt thereof. 8. The pharmaceutical composition of claim 5 , wherein the compound is or a pharmaceutically acceptable salt thereof.
Assignees
Inventors
Classifications
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9751854B2 cover?
- The present invention provides a compound of formula I: and pharmaceutically acceptable salts thereof, wherein X, R 1 , R 2 , R 3 , R 4 , R 5 , L 1 , L 2 , m, and n, are as described in the specification. Such compounds are inhibitors of VPS34 and thus useful for treating proliferative, inflammatory, or cardiovascular disorders.
- Who is the assignee on this patent?
- Millennium Pharm Inc
- What technology area does this patent fall under?
- Primary CPC classification C07D401/04. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Sep 05 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 3 related publications on this page (citations in our corpus or others sharing the same primary CPC).